Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) EBIT Margin (2018 - 2025)

Health Catalyst's EBIT Margin history spans 8 years, with the latest figure at 115.27% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 9328.0% year-over-year to 115.27%; the TTM value through Dec 2025 reached 51.7%, down 2893.0%, while the annual FY2025 figure was 51.7%, 2893.0% down from the prior year.
  • EBIT Margin reached 115.27% in Q4 2025 per HCAT's latest filing, down from 22.94% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 17.93% in Q3 2024 to a low of 115.27% in Q4 2025.
  • Average EBIT Margin over 5 years is 45.52%, with a median of 44.81% recorded in 2025.
  • Peak YoY movement for EBIT Margin: soared 3357bps in 2023, then crashed -9328bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 69.17% in 2021, then rose by 23bps to 53.13% in 2022, then rose by 18bps to 43.66% in 2023, then soared by 50bps to 21.98% in 2024, then tumbled by -424bps to 115.27% in 2025.
  • Per Business Quant, the three most recent readings for HCAT's EBIT Margin are 115.27% (Q4 2025), 22.94% (Q3 2025), and 45.95% (Q2 2025).